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Total anomalous pulmonary venous connection (TAPVC) is a potentially lethal congenital disorder that occurs when the pulmonary veins do not connect normally to the left atrium, allowing mixing of pulmonary and systemic blood 1 . In contrast to the extensive knowledge of arterial vascular patterning, little is known about the patterning of veins. Here we show that the secreted guidance molecule semaphorin 3d (Sema3d) is crucial for the normal patterning of pulmonary veins. Prevailing models suggest that TAPVC occurs when the midpharyngeal endothelial strand (MES), the precursor of the common pulmonary vein, does not form at the proper location on the dorsal surface of the embryonic common atrium 2, 3 . However, we found that TAPVC occurs in Sema3d mutant mice despite normal formation of the MES. In these embryos, the maturing pulmonary venous plexus does not anastomose uniquely with the properly formed MES. In the absence of Sema3d, endothelial tubes form in a region that is normally avascular, resulting in aberrant connections. Normally, Sema3d provides a repulsive cue to endothelial cells in this area, establishing a boundary. Sequencing of SEMA3D in individuals with anomalous pulmonary veins identified a phenylalanine-toleucine substitution that adversely affects SEMA3D function. These results identify Sema3d as a crucial pulmonary venous patterning cue and provide experimental evidence for an alternate developmental model to explain abnormal pulmonary venous connections.
Complete separation of the systemic and pulmonary circulations occurs shortly after birth in humans. In adults, the right ventricle pumps blood through the pulmonary arteries to the lungs, and oxygenated blood returns to the left atrium through the pulmonary veins. The left ventricle pumps blood to the systemic circulation, where oxygen is used by peripheral tissues, and deoxygenated blood is returned through the systemic veins to the right atrium. Improper connection of some or all of the pulmonary veins to the right atrium or systemic venous system is termed partial anomalous pulmonary venous connection (PAPVC) and TAPVC, respectively 1, 3, 4 . The end result is a left-to-right shunt that can lead to cyanosis, increased volume load on the right heart and heart failure. PAPVC has been reported in up to 1 in 140 individuals (0.7%) [5] [6] [7] [8] . TAPVC is less common but can result in severe cyanosis or congestive heart failure in infants. Left untreated, the mortality of TAPVC is 80% 9 .
In contrast to our progress in understanding the morphogenesis of the cardiac outflow tracts and great arteries, little is known about the molecular regulation of pulmonary vein formation. Early development of the pulmonary veins is similar among vertebrate species, including humans 10 ; subtle differences become evident at later stages. For example, in humans the pulmonary vein is incorporated into the back wall of the left atrium, and subsequent remodeling leaves four separate orifices 11 , whereas in mice there is a single common pulmonary vein that enters the left atrium. Descriptive anatomical studies have suggested that pulmonary veins form initially as a dorsal evagination from the posterior wall of the embryonic atrium 10 , leading researchers to speculate that abnormal venous connections arise from absent or mislocalized evaginations 2, 3 . According to this model, TAPVC is caused primarily by defects in the formation or maintenance of the MES, which is the anlage of the pulmonary veins [12] [13] [14] [15] . Recently, high-resolution three-dimensional reconstructions of avian embryos have helped clarify that the pulmonary vein derives from a greater vascular plexus within the splanchnic mesoderm 16 . Incomplete remodeling of this plexus with failure of separation into distinct pulmonary and systemic vascular zones has been postulated to be a developmental defect that could result in anomalous pulmonary venous connection 16 .
Human genetic studies of kindreds with TAPVC have provided evidence for autosomal-dominant inheritance with incomplete penetrance and variable expression 17, 18 , and genetic linkage analysis has implicated loci on human chromosome 4q12 (ref. 18) . Candidate genes in this region include the gene encoding vascular endothelial growth factor receptor 2 (KDR) and the gene encoding platelet-derived growth factor receptor α (PDGFRA). Indeed, a spectrum of inflow tract defects, including a low incidence of TAPVC, has been noted in mice after inactivation of Pdgfra either globally or in the dorsal mesocardium 19 . Overexpression of the ANKRD1 gene is also associated with TAPVC, as shown through a chromosomal translocation in one individual and a mutation in a putative PEST (ProGluSerThr) degradation motif in two affected siblings 20 . The molecular mechanisms by which perturbations in these genes might lead to anomalous connection of the pulmonary veins has yet to be described.
Class 3 semaphorins are secreted molecules that signal primarily through the neuropilin, plexin or both co-receptor complexes. Semaphorins were originally identified as axon guidance molecules but have since been implicated in multiple biological processes, including cardiovascular patterning [21] [22] [23] . For example, Sema3e is required for intersomitic artery patterning 24 , and Sema3c is required for morphogenesis of the great arteries at the arterial pole of the heart 25 . Sema3d encodes a related member of this class of proteins that has been previously implicated in retinal ganglion cell axon patterning and neural crest migration in zebrafish 26, 27 .
To determine the role of Sema3d in cardiovascular development, we inactivated the gene by homologous recombination in mouse embryonic stem cells ( Supplementary Fig. 1 and ref. 28 ). We created two distinct alleles: one resulted in truncation of the protein after the seventh amino acid residue, and in the other the coding sequence for a fusion of GFP and Cre recombinase was inserted at the initiating ATG codon. GFP expression from this allele accurately recapitulates endogenous Sema3d expression 28 . The resulting phenotypes of the two alleles were identical (data not shown). Heterozygous mice appeared normal, whereas homozygous-null mice showed abnormalities of pulmonary venous patterning. Affected Sema3d −/− adult mice had massively enlarged right atria and ventricles ( Fig. 1 and Supplementary Video 1), consistent with a left-to-right shunt. In control mice (either wild type or Sema3d +/− ), the pulmonary veins connected to the left atrium (Fig. 1a,c,e,f) . The mutant mice had anomalous connections to the coronary sinus (which connects to the right atrium) or directly to the right atrium (Fig. 1b,d ,g,h, Supplementary Video 2 and Supplementary Fig. 2 ). Thirty-five percent (14/36) of homozygousnull mutants had TAPVC or PAPVC. The majority of the affected mice had TAPVC (13/14) . TAPVC was associated with atrial septal defects in all affected Sema3d mutants. However, we did not note any other structural intracardiac defects or abnormalities of laterality in the abdominal organs of the mutant mice.
To determine when patterning defects were first evident, we examined Sema3d −/− mouse embryos at progressively earlier stages. At embryonic day (E) 17.5, optical projection tomography (OPT) imaging (Fig. 2a,b) identified examples of abnormal connections of the pulmonary vein to the coronary sinus (3 of 8 mutant embryos) (Fig. 2b) . At E12.5 ( Fig. 2c,d and Supplementary Video 3), there were also abnormal pulmonary venous connections in some (4 of 11) Sema3d mutant embryos (Fig. 2d) . Staining for expression of the endothelial marker Pecam1 at E10.5 ( Fig. 2e,f) revealed the first signs of abnormalities of vascular patterning in the region of the nascent pulmonary veins in some (4 of 10) mutant embryos, suggesting the formation of abnormal venous connections in ectopic locations (Fig. 2f) . At E9.5, there were no abnormalities in endothelial patterning (Fig. 2g,h and Supplementary Fig. 3) . Notably, the MES was easily identifiable at E9.5 and was unperturbed in Sema3d −/− embryos (0 of 9 mutant embryos) (Fig. 2g,h and Supplementary Fig. 3 ). This finding contradicts the widely held belief that failure of normal pulmonary vein formation at the site of entry to the common atrium is the primary Control Sema3d npg defect leading to TAPVC 15, 20 . Rather, our findings suggest that the patterning and connections of the pulmonary portion of the splanchnic venous plexus may be disrupted. Class 3 semaphorins signal through receptor complexes containing neuropilins 29 . We examined Sema3d expression as marked by GFP immunofluorescence in Sema3d GFPCre/+ mice and neuropilin-1 (Nrp-1) expression by immunofluorescence (Fig. 3) . At E10.5, when patterning defects were first present, Sema3d was expressed in the mesocardial reflections that form an anatomic boundary between the splanchnic mesoderm and the venous pole of the heart (Fig. 3a-c,h,i) . Nrp-1 was expressed by the MES at E9.5 and by pulmonary endothelial cells during early pulmonary vein patterning (Fig. 3d,e and Supplementary Fig. 4 ). Nrp-1 has been reported to be arterial specific in the chick 30 , although not in other systems 31, 32 . We performed double staining for Nrp-1 and Eph receptor B4 (EphB4), a marker of venous endothelium, and found that Nrp-1 and EphB4 were coexpressed on pulmonary venous endothelium (Fig. 3e,f) .
To determine whether Sema3d binds to the pulmonary vein endothelium in vivo, we incubated cryosections from wild-type E10.5 embryos with conditioned medium from HEK293T cells expressing alkaline phosphatase-tagged Sema3d (Sema3d-AP) protein. We detected Sema3d-AP binding in the region of the nascent pulmonary veins (Fig. 3g) but found no alkaline phosphatase binding on sections treated with control conditioned medium (data not shown). The pulmonary venous plexus is normally constrained entirely to the region medial to the Sema3d expression domain and anastomoses with the MES (Fig. 3h) . However, in Sema3d mutants, numerous Pecam1-positive endothelial cells and tubes penetrate the lateral and caudal boundaries and intermingle with cells that would normally express Sema3d (identified by GFP immunohistochemistry in mutant specimens) (Fig. 3i) . Quantification of serial confocal stacks confirmed significantly greater overlap of GFP and Pecam1 expression in mutants compared to controls (Fig. 3j) . Sema3d deficiency did not affect pulmonary endothelial cell proliferation or survival ( Supplementary  Fig. 5 ), suggesting that Sema3d regulates pulmonary vein patterning by directing pulmonary endothelial cell localization.
Previous work identified an avascular zone that forms within the splanchnic plexus to separate the pulmonary venous plexus from the more caudal vascular structures associated with systemic veins 16 . Notably, Sema3d was expressed specifically within this avascular zone (Supplementary Fig. 6a-g ), and this domain of Sema3d expression was inappropriately vascularized in Sema3d mutants ( Supplementary  Fig. 6h-k) . These findings are consistent with the hypothesis that the failure of this avascular region to form could result in abnormal connections, as previously postulated 16 .
Given these findings in mice, we examined humans with APVC for possible pathogenic variants in SEMA3D. We sequenced the exons of SEMA3D in 40 individuals with anomalous pulmonary venous connections (19 individuals with TAPVC and 21 individual with PAPVC) and identified several variants (Supplementary Table 1) . We found one of these variants, a c.193T>C missense mutation that results in a serine-to-proline substitution (S65P), in both the affected and control populations at approximately equal frequencies (1/20). However, a second variant, a c.1806T>A missense mutation that results in a phenylalanine-to-leucine substitution (F602L), was present only in an individual with PAVPC and not in 80 control samples (Supplementary Table 1 and Supplementary Fig. 7) . The affected individual was of European ancestry (as were 78 of 80 controls), had PAPVC with an associated ventricular septal defect and had no evidence of heterotaxy syndrome. The pattern of inheritance for this mutation could not be At this time point, the pulmonary vascular plexus coalesces into the pulmonary vein, which runs between the mesocardial folds. In the Sema3d +/− embryo (e), the pulmonary vein remains near the midline, whereas in the Sema3d −/− embryo, the pulmonary vein deviates laterally, and ectopic vessels (arrowheads) are present (f). (g,h) Pecam1 immunofluorescence at E9.5 showing no discernible abnormalities in a Sema3d −/− embryo (h) compared to a Sema3d +/− embryo (g). Notably, the MES forms normally in Sema3d −/− embryos (see Supplementary Fig. 3 for images of g and h with adjacent sections). RL, right lung bud; LL, left lung bud; DA, dorsal aorta. Scale bars (a-h), 100 µm. npg determined, as parental DNA was not available for this individual. The F602L variant is predicted to be possibly damaging to protein function by PolyPhen in silico analysis (Supplementary Table 1) , and the amino acid alteration is located in the immunoglobulin-like domain of Sema3d, which has been shown to be important for both receptor binding and functional activity 33, 34 . Additionally, the F602L variant is absent from the 1000 Genomes data set (1,092 individuals) and the National Heart, Lung, and Blood Institute Exome Sequencing Project (ESP) (13,000 chromosomes) 35 and is not among the >800 chromosomes reported previously in which SEMA3D exons were sequenced for other reasons 36, 37 .
To test the ability of wild-type and variant Sema3d to bind to neuropilin receptors and mediate the guidance of endothelial cells, we generated alkaline phosphatase fusion proteins. Binding to transfected COS-7 cells expressing Nrp-1 or Nrp-2 suggested that wild-type and both Sema3d variants tested could bind to Nrp-1, although the F602L variant bound with lower affinity (Fig. 4a and  Supplementary Fig. 8 ). We found no substantial binding to Nrp-2. Wild-type Sema3d-AP bound to human umbilical vein endothelial cells (HUVECs) (Supplementary Fig. 9 ), which normally express NRP-1 (refs. 31, 32) . This binding was significantly (P < 0.001) diminished after siRNA-mediated knockdown of NRP-1 expression (Supplementary Fig. 10) .
To determine the endothelial guidance properties of Sema3d variants, we cocultured HEK293 cells overexpressing either Sema3d or its variants with HUVECs. Time-lapse video analysis, as well as micrograph quantification, confirmed that Sema3d acts as a migratory repulsive cue in culture 21 (Fig. 4b,c and Supplementary Video 4) . The Sema3d S65P variant repelled HUVECs similarly to the wildtype protein (Fig. 4b,c) ; however, the Sema3d F602L variant had markedly reduced repulsion activity (Fig. 4b,c and Supplementary  Video 4) . To investigate whether Sema3d repulsion is mediated by NRP-1, we blocked NRP-1 signaling by adding either soluble NRP-1 or an NRP-1-specific blocking antibody to the culture medium.
Both soluble NRP-1 and the NRP-1-specific antibody significantly reduced HUVEC repulsion in response to Sema3d (Fig. 4d,e) .
Although both arterial and venous endothelia express Nrp-1, recent studies have shown that cell responsiveness to semaphorin signaling can be mediated by differential expression of co-receptors, as well as intracellular signaling factors acting downstream of receptors 38, 39 . For example, Sema3e acts as a repellent signal on neurons expressing plexin D1 but not Nrp-1 and acts as an attractive cue for neurons that express both proteins 38 . Recently, the effects of Sema3f in the central nervous system were shown to be modulated by an intracellular Rac GTPase-activating protein, β2-chimaerin (β2Chn) 39 . In the absence of β2Chn, Sema3f engagement of Nrp-2 can mediate axon repulsion, but β2Chn is required for axon pruning in response to Sema3f. Thus, the downstream effects of semaphorin-neuropilin interactions may be dictated by the expression or activities of receptors and downstream mediators.
Taken together these data implicate Sema3d as a repellent guidance molecule that functions to pattern the forming pulmonary venous vasculature (Fig. 4f) . We suggest that in the absence of Sema3d-mediated npg repulsion, the pulmonary vasculature stochastically forms anomalous connections to adjacent systemic venous structures along a broad rostral-caudal domain, which could explain the morphological variability of anomalous pulmonary vascular connections in Sema3d mutant mice and the diverse types of anomalous connections in affected humans 16 . The lack of repulsion leads to a broad domain of abnormal endothelial sprouts, which may persist when they connect to a systemic vein and receive substantial blood flow. Hence, stochastic considerations may contribute to variation in patterning. SEMA3D copy number variation has been linked to congenital heart defects 40 , and the functional deficiencies of the F602L variant suggest a possible genetic contribution to this common form of congenital heart disease in children, although further studies will be necessary to determine whether SEMA3D mutations are sufficient to cause APVC in humans and to what degree sequence variation in SEMA3D may contribute to this phenotype. Genetic variation affecting the SEMA3D signaling cascade will be an important future target of study in individuals with congenital heart disease and pulmonary venous anomalies.
Our data demonstrate a new pathophysiological mechanism for anomalous pulmonary venous connections that challenges the long-held model regarding the etiology of this congenital disorder. These findings underscore the existence of specific morphogenetic pathways affecting subtypes of the vasculature and the importance of further investigation into the nature of vascular heterogeneity in development and disease.
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Reprints and permissions information is available online at http://www.nature.com/ reprints/index.html. npg first confirmed in the affected individual and then tested in a cohort of 80 ethnically matched control samples. Because of the limited quantity of DNA available for each affected individual (<500 ng), a whole-genome amplification (WGA) reaction was required before PCR and sequencing. Briefly, 10 ng of each affected individual's DNA was used as template in the commercially available GenomiPhi V2 DNA Amplification kit (Illustra, Inc.), and each reaction was carried out according to the manufacturer's protocol. Agarose gel electrophoresis was used to assess the quality of the WGA DNA product. The final amplification product stocks for each affected individual were diluted 1:20 and stored at −20 °C for use in downstream PCR and sequencing reactions. The WGA DNA products were used as the template for all initial screening reactions of the SEMA3D coding sequence. After identification of a new coding variant in an affected individual's WGA DNA sequence, the PCR and sequencing reactions were repeated using 20 ng of the original stock DNA to confirm that the variant existed in the original DNA sample of the affected individual and was not introduced by the WGA reaction.
Statistical analyses. Two-tailed Student's t test or one-way ANOVA was used to analyze data. Significant differences calculated by ANOVA were further analyzed post hoc by Tukey's test for multiple comparisons (*P < 0.05, **P < 0.01, ***P < 0.001; NS, not significant). All data are expressed as the mean ± s.e.m.
